BeiGene Stock Rises on FDA Approval for Cancer Treatment
BGNEDelisted Stock | USD 184.71 0.71 0.39% |
About 55% of BGNE Old's investor base is interested to short. The analysis of current outlook of investing in BGNE Old suggests that many traders are impartial regarding BGNE Old's prospects. The current market sentiment, together with BGNE Old's historical and current headlines, can help investors time the market. In addition, many technical investors use BGNE Old stock news signals to limit their universe of possible portfolio assets.
BGNE |
BeiGene saw a pre-market increase of 1.16, reaching 184. The rise follows the announcement that the U.S. Food and Drug Administration has approve
Read at gurufocus.com
BGNE Old Fundamental Analysis
We analyze BGNE Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BGNE Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BGNE Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
BGNE Old is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
BGNE Old Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BGNE Old stock to make a market-neutral strategy. Peer analysis of BGNE Old could also be used in its relative valuation, which is a method of valuing BGNE Old by comparing valuation metrics with similar companies.
Peers
BGNE Old Related Equities
TVTX | Travere Therapeutics | 2.93 | ||||
ASND | Ascendis Pharma | 2.64 | ||||
LEGN | Legend Biotech | 2.36 | ||||
KRYS | Krystal Biotech | 2.35 | ||||
IONS | Ionis Pharmaceuticals | 1.34 | ||||
IMVT | Immunovant | 1.28 | ||||
INCY | Incyte | 0.53 | ||||
BMRN | Biomarin Pharmaceutical | 0.81 | ||||
BPMC | Blueprint Medicines | 1.33 | ||||
ARWR | Arrowhead Pharmaceuticals | 1.73 | ||||
AKRO | Akero Therapeutics | 2.31 | ||||
IMAB | I Mab | 3.77 | ||||
PCVX | Vaxcyte | 3.95 | ||||
APLS | Apellis Pharmaceuticals | 4.54 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in BGNE Stock
If you are still planning to invest in BGNE Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BGNE Old's history and understand the potential risks before investing.
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |